Literature DB >> 30165501

Deprescribing: the emerging evidence for and the practice of the 'geriatrician's salute'.

Sarah N Hilmer1, Danijela Gnjidic2.   

Abstract

The process of a health professional withdrawing medicines for which the current risk may outweigh the benefit in the individual patient has been given a variety of names including the colloquial 'geriatrician's salute', 'de-intensification' and increasingly 'deprescribing'. The rise of deprescribing as a word with a definition, evidence base and implementation plan, reflects the changing environment in which we practice. In particular, the emphasis on evidence-based medicine and the need to care for our expanding ageing populations, which requires application of components of geriatric evaluation and management by a wider range of health care practitioners. However, there are still significant challenges related to research on the safety, efficacy and implementation of deprescribing. In this commentary, we discuss the current evidence on the effects of deprescribing, emergence of implementation tools to embed deprescribing into the clinical care of older adults, as well as efforts to develop guidelines to improve health care practitioners' awareness and self-efficacy of deprescribing. Ultimately, judicious prescribing and deprescribing, across a wide range of health care settings, ought to enable older people to use medicines to support their achievable ageing goals.

Entities:  

Mesh:

Year:  2018        PMID: 30165501     DOI: 10.1093/ageing/afy014

Source DB:  PubMed          Journal:  Age Ageing        ISSN: 0002-0729            Impact factor:   10.668


  5 in total

1.  Medication Optimization for New Initiators of Empagliflozin for Diabetic Kidney Disease.

Authors:  Andrew A Swanner; Chelsea E Hawley; Kay Li; Laura K Triantafylidis; Jiahua Li; Julie M Paik
Journal:  Clin Diabetes       Date:  2022-04-15

Review 2.  Recommendations for outcome measurement for deprescribing intervention studies.

Authors:  Elizabeth A Bayliss; Kathleen Albers; Kathy Gleason; Lisa E Pieper; Cynthia M Boyd; Noll L Campbell; Kristine E Ensrud; Shelly L Gray; Amy M Linsky; Derelie Mangin; Lillian Min; Michael W Rich; Michael A Steinman; Justin Turner; Eduard E Vasilevskis; Sascha Dublin
Journal:  J Am Geriatr Soc       Date:  2022-06-01       Impact factor: 7.538

3.  Evaluating the impact of a polypharmacy Action Learning Sets tool on healthcare practitioners' confidence, perceptions and experiences of stopping inappropriate medicines.

Authors:  Cindy Faith Brooks; Anastasios Argyropoulos; Catherine Brigitte Matheson-Monnet; David Kryl
Journal:  BMC Med Educ       Date:  2022-06-27       Impact factor: 3.263

Review 4.  Prescribing practices, patterns, and potential harms in patients receiving palliative care: A systematic scoping review.

Authors:  Cathal A Cadogan; Melanie Murphy; Miriam Boland; Kathleen Bennett; Sarah McLean; Carmel Hughes
Journal:  Explor Res Clin Soc Pharm       Date:  2021-07-23

5.  Anticholinergic/sedative drug burden predicts worse memory acquisition in older racially/ethnically diverse patients with type 2 diabetes mellitus.

Authors:  Seth A Margolis; Malka Zughaft Sears; Lori A Daiello; Carly Solon; Luba Nakhutina; Claire J Hoogendoorn; Jeffrey S Gonzalez
Journal:  Int J Geriatr Psychiatry       Date:  2019-07-22       Impact factor: 3.485

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.